• Search
  • Helpdesk
  • Sales contact

Strengthen your eCOA strategy early
with our scientific and clinical experts

Our scientific and medical team will help you define impactful endpoints, select the most relevant questionnaires, and determine the ideal data collection method tailored to your project’s needs.

Why choose our early strategic advisory?

Strengthen your eCOA strategy

Our scientific and medical team is dedicated to providing you with customized eCOA strategy recommendations that will propel your project forward:

Learn more about scientific and clinical support

NonAlcoholic SteatoHepatitis (NASH), now called Metabolic Dysfunction-Associated SteatoHepatitis (MASH), affects almost 115 million adults globally and is the most

In contrast to paper solutions, electronic Clinical Outcome Assessment (eCOA) demonstrates strengths such as: Accuracy Completeness Timings Attributability User-friendliness

Early phase clinical research (phase 1 and 2a) focuses on characterizing the behavior of the investigational product in humans,